Very Late Stent Thrombosis after Drug-Eluting Stent Implantation in a Patient without Aspirin and Clopidogrel Resistance.
10.3346/jkms.2008.23.3.556
- Author:
Sang Yup LIM
1
;
Ki Seok KIM
;
Seung Jae JOO
;
Myung Ho JEONG
Author Information
1. Cardiovascular Center, Korea University Anam Hospital, Seoul, Korea.
- Publication Type:Case Report
- Keywords:
Stents;
Thrombosis;
Myocardial Infarction
- MeSH:
Aged;
Angina Pectoris/*therapy;
Aspirin/*therapeutic use;
Coronary Angiography;
Coronary Thrombosis/drug therapy/*etiology/radiography;
Drug Resistance;
Drug-Eluting Stents/*adverse effects;
Electrocardiography;
Female;
Humans;
Platelet Aggregation Inhibitors/*therapeutic use;
Ticlopidine/*analogs & derivatives/therapeutic use;
Time Factors
- From:Journal of Korean Medical Science
2008;23(3):556-559
- CountryRepublic of Korea
- Language:English
-
Abstract:
Very late stent thrombosis (VLST) after implantation of drug-eluting stent is rare, but very fatal complication after percutaneous coronary intervention. We report a case of VLST of a sirolimus-eluting Cypher(TM) stent (Cordis, Johnson and Johnson) presenting as acute ST elevation myocardial infarction at 26 months after deployment with continued combined dual antiplatelet medication of aspirin and clopidogrel. The patient did not show anti-platelet resistance.
